| Literature DB >> 32856123 |
Julia Föhr1, Matthias Herbst1, Sigbert Jahn2.
Abstract
Our 21-year-old woman presented with symptoms of chronic spontaneous urticaria with angioedema and of cholinergic urticaria as well as of atopic dermatitis. Treatment with the IgE antibody omalizumab resulted in an improvement of urticaria; however, relapses of the atopic dermatitis occurred. The use of the monoclonal IL-4/13 receptor antibody dupilumab resulted in complete healing of the atopic dermatitis, complete remission of the chronic spontaneous urticaria with angioedema, and the satisfactory control of cholinergic flare ups over a follow-up period of 26 weeks.Entities:
Keywords: Cholinergic urticaria; Chronic spontaneous urticaria; Eczema; Immunoglobulin E antibody; Interleukin-4/13 receptor antibody
Mesh：
Substances：
Year: 2021 PMID： 32856123 DOI： 10.1007/s00105-020-04675-3
Source DB: PubMed Journal: Hautarzt ISSN： 0017-8470 Impact factor: 0.751